Citations (85)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Sara A. Collins, Ashish H. Shah, Derek Ostertag, Noriyuki Kasahara & Douglas J. Jolly. (2021) Clinical development of retroviral replicating vector Toca 511 for gene therapy of cancer. Expert Opinion on Biological Therapy 21:9, pages 1199-1214.
Read now
Read now
Brandon D. Philbrick & D. Cory Adamson. (2019) Early clinical trials of Toca 511 and Toca FC show a promising novel treatment for recurrent malignant glioma. Expert Opinion on Investigational Drugs 28:3, pages 207-216.
Read now
Read now
Sareh Zhand, Seyed Masoud Hosseini, Alijan Tabarraei, Mohsen Saeidi, Marie Saghaeian Jazi, Mohamad Reza Kalani & Abdolvahab Moradi. (2018) Oral poliovirus vaccine-induced programmed cell death involves both intrinsic and extrinsic pathways in human colorectal cancer cells. Oncolytic Virotherapy 7, pages 95-105.
Read now
Read now
Jonathan G. Pol, Sarah Lévesque, Samuel T. Workenhe, Shashi Gujar, Fabrice Le Boeuf, Derek R. Clements, Jean-Eudes Fahrner, Laetitia Fend, John C. Bell, Karen L. Mossman, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2018) Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors. OncoImmunology 7:12.
Read now
Read now
Stefania Oliva, Manuela Gambella, Mario Boccadoro & Sara Bringhen. (2017) Systemic virotherapy for multiple myeloma. Expert Opinion on Biological Therapy 17:11, pages 1375-1387.
Read now
Read now
Amber C Miller & Stephen J Russell. (2014) Heterogeneous delivery is a barrier to the translational advancement of oncolytic virotherapy for treating solid tumors. Virus Adaptation and Treatment 6, pages 11-31.
Read now
Read now
Dominic G Roy & John C Bell. (2013) Cell carriers for oncolytic viruses: current challenges and future directions. Oncolytic Virotherapy 2, pages 47-56.
Read now
Read now
Pavlos Msaouel, Mateusz Opyrchal, Evidio Domingo Musibay & Evanthia Galanis. (2013) Oncolytic measles virus strains as novel anticancer agents. Expert Opinion on Biological Therapy 13:4, pages 483-502.
Read now
Read now
Norman Woller, Florian Kühnel & Stefan Kubicka. (2012) Virus infections in tumors pave the way for tumor-directed DC-vaccines. OncoImmunology 1:2, pages 208-210.
Read now
Read now
Patrycja J Lech & Stephen J Russell. (2010) Use of attenuated paramyxoviruses for cancer therapy. Expert Review of Vaccines 9:11, pages 1275-1302.
Read now
Read now
Articles from other publishers (75)
Kelly M. Makielski, Aaron L. Sarver, Michael S. Henson, Kathleen M. Stuebner, Antonella Borgatti, Lukkana Suksanpaisan, Caitlin Preusser, Alexandru-Flaviu Tabaran, Ingrid Cornax, M. Gerard O’Sullivan, Andrea Chehadeh, Donna Groschen, Kelly Bergsrud, Sara Pracht, Amber Winter, Lauren J. Mills, Marc D. Schwabenlander, Melissa Wolfe, Michael A. Farrar, Gary R. Cutter, Joseph S. Koopmeiners, Stephen J. Russell, Jaime F. Modiano & Shruthi Naik. (2023) Neoadjuvant systemic oncolytic vesicular stomatitis virus is safe and may enhance long-term survivorship in dogs with naturally occurring osteosarcoma. Molecular Therapy - Oncolytics 31, pages 100736.
Crossref
Crossref
Kei Tamura, Tomoko Fujiyuki, Kanako Moritoh, Hayato Akimoto, Keigo Iizuka, Hiroki Sato, Kazushi Asano, Misako Yoneda & Chieko Kai. (2023) Anti-tumor activity of a recombinant measles virus against canine lung cancer cells. Scientific Reports 13:1.
Crossref
Crossref
Darshak Kartikey Bhatt, Thijs Janzen, Toos Daemen & Franz J. Weissing. (2022) Modelling the spatial dynamics of oncolytic virotherapy in the presence of virus-resistant tumour cells. PLOS Computational Biology 18:12, pages e1010076.
Crossref
Crossref
Paige E. Solomon, Lisa L. Kirkemo, Gary M. Wilson, Kevin K. Leung, Mark H. Almond, Leanne C. Sayles, E. Alejandro Sweet-Cordero, Oren S. Rosenberg, Joshua J. Coon & James A. Wells. (2022) Discovery Proteomics Analysis Determines That Driver Oncogenes Suppress Antiviral Defense Pathways Through Reduction in Interferon-β Autocrine Stimulation. Molecular & Cellular Proteomics 21:7, pages 100247.
Crossref
Crossref
Otto Luiz Dutra Cerqueira, Fernanda Antunes, Nadine G Assis, Elaine C Cardoso, Maria A Clavijo-Salomón, Ana C Domingues, Nayara G Tessarollo & Bryan E Strauss. (2022) Perspectives for Combining Viral Oncolysis With Additional Immunotherapies for the Treatment of Melanoma. Frontiers in Molecular Biosciences 9.
Crossref
Crossref
Zahra Shokati Eshkiki, Nasibeh Khayer, Atefeh Talebi, Reza Karbalaei & Abolfazl Akbari. (2022) Novel insight into pancreatic adenocarcinoma pathogenesis using liquid association analysis. BMC Medical Genomics 15:1.
Crossref
Crossref
Sarah E. Blitz, Ari D. Kappel, Florian A. Gessler, Neil V. Klinger, Omar Arnaout, Yi Lu, Pier Paolo Peruzzi, Timothy R. Smith, Ennio A. Chiocca, Gregory K. Friedman & Joshua D. Bernstock. (2022) Tumor-Associated Macrophages/Microglia in Glioblastoma Oncolytic Virotherapy: A Double-Edged Sword. International Journal of Molecular Sciences 23:3, pages 1808.
Crossref
Crossref
Anastasiya V. Lipatova, Alesya V. Soboleva, Vladimir A. Gorshkov, Julia A. Bubis, Elizaveta M. Solovyeva, George S. Krasnov, Dmitry V. Kochetkov, Pavel O. Vorobyev, Irina Y. Ilina, Sergei A. Moshkovskii, Frank Kjeldsen, Mikhail V. Gorshkov, Peter M. Chumakov & Irina A. Tarasova. (2021) Multi-Omics Analysis of Glioblastoma Cells’ Sensitivity to Oncolytic Viruses. Cancers 13:21, pages 5268.
Crossref
Crossref
Joshua Del Papa, Ryan G. Clarkin & Robin J. Parks. (2020) Use of cell fusion proteins to enhance adenoviral vector efficacy as an anti-cancer therapeutic. Cancer Gene Therapy 28:7-8, pages 745-756.
Crossref
Crossref
Omeed Moaven, Christopher W. Mangieri, John A. Stauffer, Panos Z. Anastasiadis & Mitesh J. Borad. (2021) Strategies to Develop Potent Oncolytic Viruses and Enhance Their Therapeutic Efficacy. JCO Precision Oncology:5, pages 733-743.
Crossref
Crossref
Xu Zhang, Clément Chapat, Peng Wang, Jung-Hyun Choi, Qian Li, Jun Luo, Shane Wiebe, Sung-Hoon Kim, Nathaniel Robichaud, Isabela Fabri Karam, David Dai, Angela P. Hackett, Rongtuan Lin, Tommy Alain, Long Yang, Seyed Mehdi Jafarnejad & Nahum Sonenberg. (2021) microRNA-induced translational control of antiviral immunity by the cap-binding protein 4EHP. Molecular Cell 81:6, pages 1187-1199.e5.
Crossref
Crossref
Yevhenii Trehub & Andrii Havrilov. 2021. Cancer Immunology. Cancer Immunology
509
541
.
T. H. Le, A. V. Lipatova, M. A. Volskaya, O. A. Tikhonova & P. M. Chumakov. (2020) The State of The Jak/Stat Pathway Affects the Sensitivity of Tumor Cells to Oncolytic Enteroviruses. Molecular Biology 54:4, pages 570-577.
Crossref
Crossref
Lauro Velazquez-Salinas, Steven J. Pauszek, Lauren G. Holinka, Douglas P. Gladue, Steven I. Rekant, Elizabeth A. Bishop, Carolina Stenfeldt, Antonio Verdugo-Rodriguez, Manuel V. Borca, Jonathan Arzt & Luis L. Rodriguez. (2020) A Single Amino Acid Substitution in the Matrix Protein (M51R) of Vesicular Stomatitis New Jersey Virus Impairs Replication in Cultured Porcine Macrophages and Results in Significant Attenuation in Pigs. Frontiers in Microbiology 11.
Crossref
Crossref
Shih-Han Chen, Jui-Ming Sun, Bing-Mao Chen, Sheng-Che Lin, Hao-Fang Chang, Sara Collins, Deching Chang, Shu-Fen Wu, Yin-Che Lu, Weijun Wang, Thomas C. Chen, Noriyuki Kasahara, Hsin-Ell Wang & Chien-Kuo Tai. (2020) Efficient Prodrug Activator Gene Therapy by Retroviral Replicating Vectors Prolongs Survival in an Immune-Competent Intracerebral Glioma Model. International Journal of Molecular Sciences 21:4, pages 1433.
Crossref
Crossref
D. Kabacaoglu, D. A. Ruess & Hana Algül. 2020. Translational Pancreatic Cancer Research. Translational Pancreatic Cancer Research
203
218
.
Lauro Velazquez-Salinas, Steven J. Pauszek, Jose Barrera, Benjamin A. Clark, Manuel V. Borca, Antonio Verdugo-Rodriguez, Carolina Stenfeldt, Jonathan Arzt & Luis L. Rodriguez. (2019) Validation of a site-specific recombination cloning technique for the rapid development of a full-length cDNA clone of a virulent field strain of vesicular stomatitis New Jersey virus. Journal of Virological Methods 265, pages 113-116.
Crossref
Crossref
Delphine Lanoie, Stéphanie Côté, Emmanuelle Degeorges & Guy Lemay. (2019) A single mutation in the mammalian orthoreovirus S1 gene is responsible for increased interferon sensitivity in a virus mutant selected in Vero cells. Virology 528, pages 73-79.
Crossref
Crossref
Geetanjali Lal & Maitreyi S. Rajala. (2019) Combination of Oncolytic Measles Virus Armed With BNiP3, a Pro-apoptotic Gene and Paclitaxel Induces Breast Cancer Cell Death. Frontiers in Oncology 8.
Crossref
Crossref
Lauro Velazquez-Salinas, Steven J. Pauszek, Carolina Stenfeldt, Emily S. O’Hearn, Juan M. Pacheco, Manuel V. Borca, Antonio Verdugo-Rodriguez, Jonathan Arzt & Luis L. Rodriguez. (2018) Increased Virulence of an Epidemic Strain of Vesicular Stomatitis Virus Is Associated With Interference of the Innate Response in Pigs. Frontiers in Microbiology 9.
Crossref
Crossref
Derya Kabacaoglu, Katrin J. Ciecielski, Dietrich A. Ruess & Hana Algül. (2018) Immune Checkpoint Inhibition for Pancreatic Ductal Adenocarcinoma: Current Limitations and Future Options. Frontiers in Immunology 9.
Crossref
Crossref
Delphine Lanoie & Guy Lemay. (2018) Multiple proteins differing between laboratory stocks of mammalian orthoreoviruses affect both virus sensitivity to interferon and induction of interferon production during infection. Virus Research 247, pages 40-46.
Crossref
Crossref
Shruthi Naik, Gina D. Galyon, Nathan J. Jenks, Michael B. Steele, Amber C. Miller, Sara D. Allstadt, Lukkana Suksanpaisan, Kah Whye Peng, Mark J. Federspiel, Stephen J. Russell & Amy K. LeBlanc. (2018) Comparative Oncology Evaluation of Intravenous Recombinant Oncolytic Vesicular Stomatitis Virus Therapy in Spontaneous Canine Cancer. Molecular Cancer Therapeutics 17:1, pages 316-326.
Crossref
Crossref
Daniel E. Meyers, Satbir Thakur, Chandini M. Thirukkumaran & Don G. Morris. (2017) Oncolytic virotherapy as an immunotherapeutic strategy for multiple myeloma. Blood Cancer Journal 7:12.
Crossref
Crossref
Blake A. Jacobson, Ahad A. Sadiq, Shaogeng Tang, Joe Jay-Dixon, Manish R. Patel, Jeremy Drees, Brent S. Sorenson, Stephen J. Russell & Robert A. Kratzke. (2017) Cap-dependent translational control of oncolytic measles virus infection in malignant mesothelioma. Oncotarget 8:38, pages 63096-63109.
Crossref
Crossref
Kei Hiraoka, Akihito Inagaki, Yuki Kato, Tiffany T. Huang, Leah A. Mitchell, Shuichi Kamijima, Masamichi Takahashi, Hiroshi Matsumoto, Katrin Hacke, Carol A. Kruse, Derek Ostertag, Joan M. Robbins, Harry E. Gruber, Douglas J. Jolly & Noriyuki Kasahara. (2017) Retroviral replicating vector?mediated gene therapy achieves long-term control of tumor recurrence and leads to durable anticancer immunity. Neuro-Oncology 19:7, pages 918-929.
Crossref
Crossref
Lauro Velazquez-Salinas, Shruthi NaikSteven J. Pauszek, Kah-Whye PengStephen J. Russell & Luis L. Rodriguez. (2017) Oncolytic Recombinant Vesicular Stomatitis Virus (VSV) Is Nonpathogenic and Nontransmissible in Pigs, a Natural Host of VSV. Human Gene Therapy Clinical Development 28:2, pages 108-115.
Crossref
Crossref
Stephen J. Russell & Kah-Whye Peng. (2017) Oncolytic Virotherapy: A Contest between Apples and Oranges. Molecular Therapy 25:5, pages 1107-1116.
Crossref
Crossref
O. P. Zhirnov. (2017) Paramyxoviruses activation by host proteases in cultures of normal and cancer cells. Problems of Virology 62:2, pages 65-72.
Crossref
Crossref
Liu Ying, Hu Cheng, Xu Wen Xiong, Lin Yuan, Zhang Hai Peng, Zhong Wen Wen, Liang Jian Ka, Xiao Xiao, Cai Jing, Tan Ya Qian, Gao Zhi Liang, Yan Guang Mei, Zhu Wen Bo & Peng Liang. (2017) Interferon alpha antagonizes the anti-hepatoma activity of the oncolytic virus M1 by stimulating anti-viral immunity. Oncotarget 8:15, pages 24694-24705.
Crossref
Crossref
Amy H. Lin, Christopher G. Twitty, Ryan Burnett, Andrew Hofacre, Leah A. Mitchell, Fernando Lopez Espinoza, Harry E. Gruber & Douglas J. Jolly. (2017) Retroviral Replicating Vector Delivery of miR-PDL1 Inhibits Immune Checkpoint PDL1 and Enhances Immune Responses In Vitro. Molecular Therapy - Nucleic Acids 6, pages 221-232.
Crossref
Crossref
Silvia RaveraAndrea Reyna-NeyraGiuseppe FerrandinoL. Mario Amzel & Nancy Carrasco. (2017) The Sodium/Iodide Symporter (NIS): Molecular Physiology and Preclinical and Clinical Applications. Annual Review of Physiology 79:1, pages 261-289.
Crossref
Crossref
Sarah Aref, Katharine Bailey & Adele Fielding. (2016) Measles to the Rescue: A Review of Oncolytic Measles Virus. Viruses 8:10, pages 294.
Crossref
Crossref
Matteo Samuele Pizzuto, Micol Silic-Benussi, Vincenzo Ciminale, Ruth A. Elderfield, Ilaria Capua & Wendy S. Barclay. (2016) An engineered avian-origin influenza A virus for pancreatic ductal adenocarcinoma virotherapy. Journal of General Virology 97:9, pages 2166-2179.
Crossref
Crossref
Emmanuel Thomas & T. Jake Liang. (2016) Experimental models of hepatitis B and C — new insights and progress. Nature Reviews Gastroenterology & Hepatology 13:6, pages 362-374.
Crossref
Crossref
Amber Miller, Rebecca Nace, Camilo Ayala-Breton C, Michael Steele, Kent Bailey, Kah Whye Peng & Stephen J Russell. (2016) Perfusion Pressure Is a Critical Determinant of the Intratumoral Extravasation of Oncolytic Viruses. Molecular Therapy 24:2, pages 306-317.
Crossref
Crossref
Andrea Marie Ibrahim. (2016) Viro-immune therapy: A new strategy for treatment of pancreatic cancer. World Journal of Gastroenterology 22:2, pages 748.
Crossref
Crossref
Marcela Cataldi, Nirav R. Shah, Sébastien A. Felt & Valery Z. Grdzelishvili. (2015) Breaking resistance of pancreatic cancer cells to an attenuated vesicular stomatitis virus through a novel activity of IKK inhibitor TPCA-1. Virology 485, pages 340-354.
Crossref
Crossref
Marlena M. Westcott, Jingfang Liu, Karishma Rajani, Ralph D'AgostinoJr.Jr., Douglas S. Lyles & Mercedes Porosnicu. (2015) Interferon Beta and Interferon Alpha 2a Differentially Protect Head and Neck Cancer Cells from Vesicular Stomatitis Virus-Induced Oncolysis. Journal of Virology 89:15, pages 7944-7954.
Crossref
Crossref
Benjamin Ruf, Susanne Berchtold, Sascha Venturelli, Markus Burkard, Irina Smirnow, Tanja Prenzel, Stefan W Henning & Ulrich M Lauer. (2015) Combination of the oral histone deacetylase inhibitor resminostat with oncolytic measles vaccine virus as a new option for epi-virotherapeutic treatment of hepatocellular carcinoma. Molecular Therapy - Oncolytics 2, pages 15019.
Crossref
Crossref
Claire E. Stewart, Richard E. Randall & Catherine S. Adamson. (2014) Inhibitors of the Interferon Response Enhance Virus Replication In Vitro. PLoS ONE 9:11, pages e112014.
Crossref
Crossref
Yuan LinHaipeng ZhangJiankai LiangKai LiWenbo ZhuLiwu Fu, Fang Wang, Xiaoke Zheng, Huijuan Shi, Sihan WuXiao XiaoLijun ChenLipeng TangMin YanXiaoxiao YangYaqian TanPengxin QiuYijun HuangWei Yin, Xinwen SuHaiyan HuJun Hu & Guangmei Yan. (2014) Identification and characterization of alphavirus M1 as a selective oncolytic virus targeting ZAP-defective human cancers. Proceedings of the National Academy of Sciences 111:42.
Crossref
Crossref
Valérie Janelle & Alain Lamarre. (2014) How Informative is the Immune Response Against Surrogate Tumor Antigens to Assess Antitumor Immunity?. Frontiers in Oncology 4.
Crossref
Crossref
Sebastien Delpeut, Ryan Noyce & Christopher Richardson. (2014) The Tumor-Associated Marker, PVRL4 (Nectin-4), Is the Epithelial Receptor for Morbilliviruses. Viruses 6:6, pages 2268-2286.
Crossref
Crossref
Valérie Janelle, Marie-Pierre Langlois, Pascal Lapierre, Tania Charpentier, Laurent Poliquin & Alain Lamarre. (2014) The Strength of the T Cell Response Against a Surrogate Tumor Antigen Induced by Oncolytic VSV Therapy Does Not Correlate With Tumor Control. Molecular Therapy 22:6, pages 1198-1210.
Crossref
Crossref
Meaghan L Khan, Thorvardur R Halfdanarson & Mitesh J Borad. (2014) Immunotherapeutic and oncolytic viral therapeutic strategies in pancreatic cancer. Future Oncology 10:7, pages 1255-1275.
Crossref
Crossref
Zong Sheng Guo, Zuqiang Liu & David L. Bartlett. (2014) Oncolytic Immunotherapy: Dying the Right Way is a Key to Eliciting Potent Antitumor Immunity. Frontiers in Oncology 4.
Crossref
Crossref
Aaron U. Blackham, Scott A. Northrup, Mark Willingham, Joseph Sirintrapun, Greg B. Russell, Douglas S. Lyles & John H. StewartIVIV. (2014) Molecular determinants of susceptibility to oncolytic vesicular stomatitis virus in pancreatic adenocarcinoma. Journal of Surgical Research 187:2, pages 412-426.
Crossref
Crossref
Martina Zimmermann, Sorin Armeanu-Ebinger, Sascha Bossow, Johanna Lampe, Irina Smirnow, Andrea Schenk, Sebastian Lange, Thomas S. Weiss, Wolfgang Neubert, Ulrich M. Lauer & Michael Bitzer. (2014) Attenuated and Protease-Profile Modified Sendai Virus Vectors as a New Tool for Virotherapy of Solid Tumors. PLoS ONE 9:3, pages e90508.
Crossref
Crossref
Tanner S. Miest & Roberto Cattaneo. (2013) New viruses for cancer therapy: meeting clinical needs. Nature Reviews Microbiology 12:1, pages 23-34.
Crossref
Crossref
Markus Vähä-Koskela, Siri Tähtinen, Susanna Grönberg-Vähä-Koskela, Kristian Taipale, Dipongkor Saha, Maiju Merisalo-Soikkeli, Marko Ahonen, Noora Rouvinen-Lagerström, Mari Hirvinen, Ville Veckman, Sampsa Matikainen, Fang Zhao, Päivi Pakarinen, Jarmo Salo, Anna Kanerva, Vincenzo Cerullo & Akseli Hemminki. (2014) Overcoming tumor resistance by heterologous adeno-poxvirus combination therapy. Molecular Therapy - Oncolytics 1, pages 14006.
Crossref
Crossref
David L Bartlett, Zuqiang Liu, Magesh Sathaiah, Roshni Ravindranathan, Zongbi Guo, Yukai He & Zong Sheng Guo. (2013) Oncolytic viruses as therapeutic cancer vaccines. Molecular Cancer 12:1.
Crossref
Crossref
Amy K. LeBlancShruthi NaikGina D. GalyonNathan JenksMike SteeleKah-Whye PengMark J. FederspielRobert DonnellStephen J. Russell. (2013) Safety Studies on Intravenous Administration of Oncolytic Recombinant Vesicular Stomatitis Virus in Purpose-Bred Beagle Dogs. Human Gene Therapy Clinical Development 24:4, pages 174-181.
Crossref
Crossref
D Escobar-Zarate, Y-P Liu, L Suksanpaisan, S J Russell & K-W Peng. (2013) Overcoming cancer cell resistance to VSV oncolysis with JAK1/2 inhibitors. Cancer Gene Therapy 20:10, pages 582-589.
Crossref
Crossref
Eric Hastie, Marcela Cataldi, Ian Marriott & Valery Z. Grdzelishvili. (2013) Understanding and altering cell tropism of vesicular stomatitis virus. Virus Research 176:1-2, pages 16-32.
Crossref
Crossref
Yu-Ping Liu, Lukkana Suksanpaisan, Michael B. Steele, Stephen J. Russell & Kah-Whye Peng. (2013) Induction of antiviral genes by the tumor microenvironment confers resistance to virotherapy. Scientific Reports 3:1.
Crossref
Crossref
C Batenchuk, F Le Boeuf, L Stubbert, T Falls, H L Atkins, J C Bell & D P Conrad. (2013) Non-replicating rhabdovirus-derived particles (NRRPs) eradicate acute leukemia by direct cytolysis and induction of antitumor immunity. Blood Cancer Journal 3:7, pages e123-e123.
Crossref
Crossref
F. J. Zemp, X. Lun, B. A. McKenzie, H. Zhou, L. Maxwell, B. Sun, J. J. P. Kelly, O. Stechishin, A. Luchman, S. Weiss, J. G. Cairncross, M. G. Hamilton, B. A. Rabinovich, M. M. Rahman, M. R. Mohamed, S. Smallwood, D. L. Senger, J. Bell, G. McFadden & P. A. Forsyth. (2013) Treating brain tumor-initiating cells using a combination of myxoma virus and rapamycin. Neuro-Oncology 15:7, pages 904-920.
Crossref
Crossref
Fabrice Le Bœuf, Cory Batenchuk, Markus Vähä-Koskela, Sophie Breton, Dominic Roy, Chantal Lemay, Julie Cox, Hesham Abdelbary, Theresa Falls, Girija Waghray, Harold Atkins, David Stojdl, Jean-Simon Diallo, Mads Kærn & John C. Bell. (2013) Model-based rational design of an oncolytic virus with improved therapeutic potential. Nature Communications 4:1.
Crossref
Crossref
Markus J. V. Vähä-Koskela, Fabrice Le Boeuf, Chantal Lemay, Naomi De Silva, Jean-Simon Diallo, Julie Cox, Michelle Becker, Youngmin Choi, Abhirami Ananth, Clara Sellers, Sophie Breton, Dominic Roy, Theresa Falls, Jan Brun, Akseli Hemminki, Ari Hinkkanen & John C. Bell. (2013) Resistance to Two Heterologous Neurotropic Oncolytic Viruses, Semliki Forest Virus and Vaccinia Virus, in Experimental Glioma. Journal of Virology 87:4, pages 2363-2366.
Crossref
Crossref
Megan Moerdyk-Schauwecker, Nirav R. Shah, Andrea M. Murphy, Eric Hastie, Pinku Mukherjee & Valery Z. Grdzelishvili. (2013) Resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus: Role of type I interferon signaling. Virology 436:1, pages 221-234.
Crossref
Crossref
Zahari Raykov, Svitlana P. Grekova, Rita Hörlein, Barbara Leuchs, Thomas Giese, Nathalia A. Giese, Jean Rommelaere, Rainer Zawatzky & Laurent Daeffler. (2013) TLR-9 Contributes to the Antiviral Innate Immune Sensing of Rodent Parvoviruses MVMp and H-1PV by Normal Human Immune Cells. PLoS ONE 8:1, pages e55086.
Crossref
Crossref
Katerina I. LeonovaLeonid BrodskyBrittany LipchickMahadeb PalLiliya NovototskayaAlex A. ChenchikGanes C. Sen, Elena A. KomarovaAndrei V. Gudkov. (2012) p53 cooperates with DNA methylation and a suicidal interferon response to maintain epigenetic silencing of repeats and noncoding RNAs. Proceedings of the National Academy of Sciences 110:1.
Crossref
Crossref
Eric Hastie & Valery Z. Grdzelishvili. (2012) Vesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancer. Journal of General Virology 93:12, pages 2529-2545.
Crossref
Crossref
Omar D Perez, Christopher R Logg, Kei Hiraoka, Oscar Diago, Ryan Burnett, Akihito Inagaki, Dawn Jolson, Karin Amundson, Taylor Buckley, Dan Lohse, Amy Lin, Cindy Burrascano, Carlos Ibanez, Noriyuki Kasahara, Harry E Gruber & Douglas J Jolly. (2012) Design and Selection of Toca 511 for Clinical Use: Modified Retroviral Replicating Vector With Improved Stability and Gene Expression. Molecular Therapy 20:9, pages 1689-1698.
Crossref
Crossref
Fabrice Le Boeuf, Nima Niknejad, Jiahu Wang, Rebecca Auer, Johanne I. Weberpals, John C. Bell & Jim Dimitroulakos. (2012) Sensitivity of cervical carcinoma cells to vesicular stomatitis virus-induced oncolysis: Potential role of human papilloma virus infection. International Journal of Cancer 131:3, pages E204-E215.
Crossref
Crossref
Stephen J Russell, Kah-Whye Peng & John C Bell. (2012) Oncolytic virotherapy. Nature Biotechnology 30:7, pages 658-670.
Crossref
Crossref
S Naik, R Nace, G N Barber & S J Russell. (2012) Potent systemic therapy of multiple myeloma utilizing oncolytic vesicular stomatitis virus coding for interferon-β. Cancer Gene Therapy 19:7, pages 443-450.
Crossref
Crossref
Andrea M. Murphy, Dahlia M. Besmer, Megan Moerdyk-Schauwecker, Natascha Moestl, David A. Ornelles, Pinku Mukherjee & Valery Z. Grdzelishvili. (2012) Vesicular Stomatitis Virus as an Oncolytic Agent against Pancreatic Ductal Adenocarcinoma. Journal of Virology 86:6, pages 3073-3087.
Crossref
Crossref
Qunfang Li & Michael A. Tainsky. (2011) Epigenetic Silencing of IRF7 and/or IRF5 in Lung Cancer Cells Leads to Increased Sensitivity to Oncolytic Viruses. PLoS ONE 6:12, pages e28683.
Crossref
Crossref
Ibtissam Echchgadda, Te-Hung Chang, Ahmed Sabbah, Imad Bakri, Yuji Ikeno, Gene B Hubbard, Bandana Chatterjee & Santanu Bose. (2011) Oncolytic targeting of androgen-sensitive prostate tumor by the respiratory syncytial virus (RSV): consequences of deficient interferon-dependent antiviral defense. BMC Cancer 11:1.
Crossref
Crossref
J H Stewart, M Ahmed, S A Northrup, M Willingham & D S Lyles. (2011) Vesicular stomatitis virus as a treatment for colorectal cancer. Cancer Gene Therapy 18:12, pages 837-849.
Crossref
Crossref
Heather MacTavish, Jean-Simon Diallo, Baocheng Huang, Marianne Stanford, Fabrice Le Boeuf, Naomi De Silva, Julie Cox, John Graydon Simmons, Tanya Guimond, Theresa Falls, J. Andrea McCart, Harry Atkins, Caroline Breitbach, David Kirn, Stephen Thorne & John C. Bell. (2010) Enhancement of Vaccinia Virus Based Oncolysis with Histone Deacetylase Inhibitors. PLoS ONE 5:12, pages e14462.
Crossref
Crossref
Septimiu Bucurescu. (2010) Development of a selective biopharmaceutical from Herpes simplex virus type 1 glycoproteins E and I for blocking antibody mediated neutralization of oncolytic viruses. Acta Pharmaceutica 60:4.
Crossref
Crossref
Alejandra Larrieux & Rafael Sanjuan. (2022) Resistance to an Oncolytic Virus Is Mediated by Broad But Reproducible Gene Expression Changes in Mouse Melanoma Cells. SSRN Electronic Journal.
Crossref
Crossref